GenesisCare continues to expand Spanish cancer services with Elekta

By News Release
0  Votes

Elekta has announced that GenesisCare will acquire Versa HD linear accelerators to help fulfil its ambition to improve cancer care for patients in Spain. The deal also includes Elekta’s MOSAIQ oncology information system to optimize the clinical care and operational efficiency of GenesisCare in Spain.

Francois Pointurier, Elekta’s senior vice president region EMEA, says: “Although we have seen an increase in the incidence of cancer in Spain, the number of cancer deaths has fallen, thanks in part to improved treatment using advanced radiation therapy devices. We are proud to continue to partner with GenesisCare as they expand in Spain and grow in the European market. GenesisCare will receive the most advanced and recognized cancer treatment solutions on the market. We look forward to providing the platforms to support GenesisCare’s vision to provide accurate, efficient and high quality treatment.”

Following the recent acquisition of oncology groups, IMOncology and Oncosur, GenesisCare is now the largest cancer care provider in Spain.

Dan Collins, Managing Director at GenesisCare, says: “By investing in the latest technology and staff training we are providing our patients with access to more efficient and effective care. This will enable our physicians and staff to offer a smoother patient experience and improve patient outcomes. The suite of advanced technology solutions, global influence and commitment to innovation offered by Elekta will support our shared efforts to improve cancer services across Spain.”

Versa HD is Elekta’s most advanced linear accelerator, used to accurately and quickly deliver radiation therapy. MOSAIQ is a comprehensive oncology information system that centralizes traditional radiation oncology, particle therapy and medical oncology patient data into a single user interface, accessible by multidisciplinary teams across multiple locations.

The order is valued at EUR 25 million, of which approximately EUR 9.5 million was booked in the second quarter of Elekta’s fiscal year. This agreement is in addition to an earlier deal with GenesisCare announced March 31, 2016. 

Back To Top

GenesisCare continues to expand Spanish cancer services with Elekta.  Appl Rad Oncol. 

By News Release| November 13, 2016
Categories:  Technologies|Section

About the Author

News Release

News Release


Copyright © Anderson Publishing, Ltd